Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease

European Journal of Health Economics

Volumn 13, Issue 4, 2012, Pages 429-443

  Gillespie, Paddy ^a   O'Shea, Eamon ^a   Murphy, Andrew W ^a   Smith, Susan M ^b   Byrne, Mary C ^a   Byrne, Molly ^a   Cupples, Margaret E ^c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Coronary heart disease; Cost effectiveness analysis: Subgroup analysis; General practice; Secondary prevention

Indexed keywords

AGED; ARTICLE; BUDGET; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEART INFARCTION; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPULATION RESEARCH; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS;

EID: 84865601722     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-011-0314-2     Document Type: Article

References (33)

1. Clark, A.M., Hartling, L., Vandermeer, B., McAlister, F.A.: Meta-analysis: Secondary prevention programs for patients with coronary artery disease. Ann. Intern. Med. 143(9), 659-672 (2005)
2. Drummond, M.F., Sculpher, M.J., Torrance, G.W., O'Brien, J., Stoddart, G.L.: Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford (2005)
3. Sun, X., Faunce, T.: Decision-analytical modelling in health-care economic evaluations. Eur. J. Health Econ. 9, 313-323 (2008)
4. Taylor, D.C.A., Pandya, A., Thompson, D., Chu, P., Graff, J., Shepherd, J., Wenger, N., Greten, H., Carmena, R., Drummond, M.F., Weinstein, M.C.: Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the treating to new targets study. Eur. J. Health Econ. 10, 255-265 (2009)
5. Gillespie, P., O'Shea, E., Murphy, A.W., Smith, S.M., Byrne, M.C., Byrne, M., Cupples, M.E.: The cost effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease. Int. J. Technol. Assess. Health Care. 26(3), 263-271 (2010)
6. Murphy, A.W., Cupples, M.E., Smith, S., Byrne, M., Byrne, M.C., Newell, J.: Secondary prevention of heart disease in general practice: A cluster randomised controlled trial of tailored practice and patient care plans. Br. Med. J. 339, b4220 (2009). doi:10.1136/bmj.b4220)
7. Murphy, A.W., Cupples, M.E., Smith, S., Byrne, M., Leathem, C., Byrne, M.C.: The SPHERE Study. Secondary prevention of heart disease in general practice: Protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]. Curr. Control Trials Cardiovasc. Med. 6, 11 (2005)
8. Fenwick, E., Byford, S.: A guide to cost effectiveness acceptability curves. Br. J. Psychiatr. 187, 106-108 (2005) (Pubitemid 41139681)
9. D'Agostino, R.B., Russell, M., Huse, D.M., Ellison, R.C., Silbershatz, H., Wilson, P.W., Hartz, S.C.: Primary and subsequent coronary risk appraisal: New results from The Framingham Study. Am. Heart J. 139, 272-281 (2000) (Pubitemid 30090804)
10. Barry, M., Tilson, L.: Recent developments in pricing and reimbursement of medicines in Ireland. Expert Rev. Pharmacoeconomics Outcomes Res. 7, 605-611 (2007)
11. National Institute for Clinical Excellence: Guide to the methods of technology appraisal. London: NICE, Apr 2004. www.nice. org.uk/page.aspx?o= 201974 (reference 0515)
12. Ware, J.E., Kosinski, M., Keller, S.D.: A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med. Care 34(3), 220-233 (1996) (Pubitemid 126433231)
13. Brazier, J.E., Roberts, J.: Estimating a preference-based index from the SF-12. Med. Care 42(9), 851-859 (2004)
14. Campbell, M.K., Elbourne, D.R., Altman, D.G.: CONSORT statement: Extension to cluster randomised trials. BMJ 328, 702-708 (2004) (Pubitemid 38393415)
15. Central Statistics Office: Dublin (www.cso.ie
16. Department of Health and Children: The National Heartwatch Programme: Clinical Report -March 2003 to December 2005. Dublin. (2006)
17. Robinson, M., Palmer, S., Sculpher, M., Philips, Z., Ginnelly, L., Bowens, A., Golder, S., Alfakih, K., Bakhai, A., Packham, C., Cooper, N., Abrams, K., Eastwood, A., Pearman, A., Flather, M., Gray, D., Hall, A.: Cost effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: Systematic review and decision-analytical modelling. Health Technol. Assess. 9(27), 1-172 (2005)
18. Hardin, J.W., Hilbe, J.M.: Generalised estimating equations. Chapman and Hall/CRC Press, London (2003)
19. Glick, H.A., Doshi, J.A., Sonnad, S.S., Polsky, D.: Economic evaluation in clinical trials. Oxford University Press, Oxford (2007)
20. Thompson, S.G., Nixon, R.M., Grieve, R.: Addressing the issues that arise in analysing multicentre cost data with application to a multinational study. J Health Econ. 25, 1015-1028 (2006) (Pubitemid 44572505)
21. Netten, A., Curtis, J.: Unit costs of health and social care. Personal Social Services Research Unit, University of Kent, Canterbury (2006)
22. Central Bank of Ireland: Dublin (www.centralbank.ie
23. Manca, A., Hawkins, N., Sculpher, M.: Estimating mean QALYs in trial based cost effectiveness analysis: The importance of controlling for baseline utility. Health Econ. 14, 487-496 (2005) (Pubitemid 40723857)
24. Lacey, E.A., Walters, S.J.: Continuing inequality: Gender and social class influences on self perceived health after a heart attack. J. Epidemiol. Commun. Health 57, 622-627 (2003) (Pubitemid 36930291)
25. Davies, A., Hutton, J., o'Donnell, J., Kingslake, S.: Cost effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK. Br. J. Cardiol. 13, 196-202 (2006) (Pubitemid 43950885)
26. Briggs, A., Claxton, K., Sculpher, M.: Decision modelling for health economic evaluation. Oxford University Press, Oxford (2005)
27. Black, W.C.: The cost effectiveness plane: A graphic representation of cost effectiveness. Med. Decis. Making 10, 212-215 (1990)
28. Johnston, K., Gray, A., Moher, M., Yudkin, P., Wright, L., Mant, D.: Reporting the cost-effectiveness of interventions with nonsignificant effect differences: Example from a trial of secondary prevention of heart disease. Int. J. Technol. Assess. Health Care 19(3), 476-489 (2003) (Pubitemid 38649116)
29. Buckley, B.S., Simpson, C.R., McLernon, D.J., Murphy, A.W., Hannaford, P.C.: Five year prognosis in patients with angina identified in primary care: Incident cohort study. BMJ 339, b3058 (2009)
30. Briggs, A.: A Bayesian approach to stochastic cost effectiveness analysis: An illustration and application to blood pressure control in type 2 diabetes. Int. J. Technol. Assess. Health Care 17(1), 69-82 (2001) (Pubitemid 32381742)
31. O'Neill, C., Normand, C., Cupples, M., McKnight, A.: Cost effectiveness of personal health education in primary care for people with angina in the Greater Belfast area of Northern Ireland. J. Epidemiol. Commun. Health 50, 538-540 (1996) (Pubitemid 26387990)
32. Raftery, J.P., Yao, G.L., Murchie, P., Campbell, N.C., Ritchie, L.D.: Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: Follow up of a randomised controlled trial. BMJ 330(7493), 707 (2005)
33. Turner, D.A., Paul, S.K., Stone, M., Juarez-Garcia, A., Squire, I., Khunti, K.: Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care. Heart 94, 1601-1606 (2008)